ACE inhibitors
Five independent economic analyses collectively show ACE       inhibitors, at worst, to be very cost effective (in comparison to other       cardiovascular therapies), cost neutral or to lead to overall cost savings when       used to treat heart failure.
Five independent economic analyses collectively show  @SUBJECT$ , at worst, to be very cost effective (in  @PREDICAT$  to other        @OBJECT$ ), cost neutral or to lead to overall cost savings when       used to treat heart failure.